BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6275785)

  • 1. In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
    Jones RN; Barry AL; Thornsberry C; Wilson HW
    Antimicrob Agents Chemother; 1981 Dec; 20(6):760-8. PubMed ID: 6275785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin.
    Scully BE; Jules K; Neu HC
    Antimicrob Agents Chemother; 1983 Jun; 23(6):907-13. PubMed ID: 6311090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in-vitro activity of cefodizime: a review.
    Soussy CJ; Chanal M; Kitzis MD
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():13-21. PubMed ID: 2074248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefodizime.
    Knothe H; Shah PM
    Infection; 1992; 20 Suppl 1():S3-8. PubMed ID: 1526673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of cefodizime (HR-221).
    Ahonkhai VI; Cherubin CE; Shulman MA
    Antimicrob Agents Chemother; 1982 Oct; 22(4):715-8. PubMed ID: 6295264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
    Pruksachatvuthi S; Aswapokee N; Aswapokee P
    J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
    Jones RN; Thornsberry C
    Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
    Fuchs PC; Jones RN; Thornsberry C; Barry AL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1981 Dec; 20(6):747-59. PubMed ID: 6275784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.
    Neu HC; Meropol NJ; Fu KP
    Antimicrob Agents Chemother; 1981 Mar; 19(3):414-23. PubMed ID: 6972729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity.
    Limbert M; Klesel N; Seeger K; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1984 Aug; 37(8):892-900. PubMed ID: 6090373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
    Okonogi K; Kuno M; Kida M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.
    Jones RN; Thornsberry C; Barry AL
    Antimicrob Agents Chemother; 1984 Jun; 25(6):710-8. PubMed ID: 6611135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.